Healthcare provider profile · identity verified

Jacob Borgsmiller, DO

Family Practice · SHAWNEE, OK · NPI 1629518295

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	506	141
Atorvastatin Calcium	Atorvastatin Calcium	413	117
Gabapentin	Gabapentin	378	86
Lisinopril	Lisinopril	338	99
Rosuvastatin Calcium	Rosuvastatin Calcium	330	83
Omeprazole	Omeprazole	306	86
Levothyroxine Sodium	Levothyroxine Sodium	296	75
Metformin Hcl	Metformin Hcl	208	56
Losartan Potassium	Losartan Potassium	206	55
Montelukast Sodium	Montelukast Sodium	191	50
Ozempic	Semaglutide	189	33
Furosemide	Furosemide	183	48
Escitalopram Oxalate	Escitalopram Oxalate	181	46
Carvedilol	Carvedilol	173	55
Tamsulosin Hcl	Tamsulosin Hcl	172	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	146	35
Pantoprazole Sodium	Pantoprazole Sodium	143	42
Olmesartan Medoxomil	Olmesartan Medoxomil	138	44
Potassium Chloride	Potassium Chloride	137	42
Clopidogrel	Clopidogrel Bisulfate	131	31
Allopurinol	Allopurinol	127	32
Trulicity	Dulaglutide	124	20
Metoprolol Tartrate	Metoprolol Tartrate	119	28
Hydrochlorothiazide	Hydrochlorothiazide	117	39
Fluticasone Propionate	Fluticasone Propionate	109	29
Alprazolam	Alprazolam	105	15
Eliquis	Apixaban	102	21
Simvastatin	Simvastatin	102	29
Tizanidine Hcl	Tizanidine Hcl	101	31
Metformin Hcl Er	Metformin Hcl	100	34
Meloxicam	Meloxicam	99	25
Pregabalin	Pregabalin	98	27
Trazodone Hcl	Trazodone Hcl	92	23
Fluoxetine Hcl	Fluoxetine Hcl	91	19
Albuterol Sulfate Hfa	Albuterol Sulfate	86	32
Jardiance	Empagliflozin	85	19
Metoprolol Succinate	Metoprolol Succinate	83	22
Oxybutynin Chloride Er	Oxybutynin Chloride	81	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	16
Pravastatin Sodium	Pravastatin Sodium	79	25
Duloxetine Hcl	Duloxetine Hcl	77	18
Ibuprofen	Ibuprofen	76	22
Tramadol Hcl	Tramadol Hcl	75	19
Buspirone Hcl	Buspirone Hcl	74	16
Celecoxib	Celecoxib	72	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	20
Ondansetron Odt	Ondansetron	68	22
Farxiga	Dapagliflozin Propanediol	67	18
Rybelsus	Semaglutide	66	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	18
Doxazosin Mesylate	Doxazosin Mesylate	62	17
Aripiprazole	Aripiprazole	61	15
Finasteride	Finasteride	60	22
Ezetimibe	Ezetimibe	58	13
Ropinirole Hcl	Ropinirole Hcl	57	12
Sertraline Hcl	Sertraline Hcl	52	13
Famotidine	Famotidine	51	16
Glimepiride	Glimepiride	48	suppressed
Citalopram Hbr	Citalopram Hydrobromide	47	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	25
Azithromycin	Azithromycin	41	38
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	12
Glipizide Er	Glipizide	41	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	13
Glipizide	Glipizide	39	14
Atenolol	Atenolol	38	12
Donepezil Hcl	Donepezil Hcl	38	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	12
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Methylprednisolone	Methylprednisolone	36	33
Spironolactone	Spironolactone	36	13
Cephalexin	Cephalexin	35	29
Januvia	Sitagliptin Phosphate	34	suppressed
Testosterone Cypionate	Testosterone Cypionate	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Naproxen	Naproxen	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	16
Memantine Hcl	Memantine Hcl	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	24	suppressed
Azelastine Hcl	Azelastine Hcl	24	12
Baclofen	Baclofen	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Nystatin	Nystatin	24	16
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Myrbetriq	Mirabegron	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Repatha Sureclick	Evolocumab	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Fluconazole	Fluconazole	16	14
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Ramipril	Ramipril	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Nurtec Odt	Rimegepant Sulfate	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Pen Needle	Pen Needle, Diabetic	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	12	suppressed
Estradiol	Estradiol	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Prednisone	Prednisone	12	11
Topiramate	Topiramate	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Irbesartan	Irbesartan	11	suppressed
Linzess	Linaclotide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error